 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/15/2024 |
$1.30 |
$1.37 |
$1.24 |
$1.31 |
1.27M | | 04/16/2024 |
$1.28 |
$1.35 |
$1.25 |
$1.30 |
863.70K | | 04/17/2024 |
$1.30 |
$1.33 |
$1.24 |
$1.27 |
1.03M | | 04/18/2024 |
$1.26 |
$1.29 |
$1.14 |
$1.17 |
1.28M | | 04/19/2024 |
$1.16 |
$1.18 |
$1.05 |
$1.15 |
1.31M |
|
|
| FibroGen is a biopharmaceutical company that developes and commercializes a pipeline of therapeutics. Co. applies its capability in hypoxia-inducible factor (HIF) biology and connective tissue growth factor (CTGF) biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. Roxadustat, Co.'s main product, is an inhibitor of HIF-prolyl hydroxylase activity that acts by stimulating the body's natural pathway of erythropoiesis or red blood cell production. Pamrevlumab is Co.'s human monoclonal antibody that inhibits the activity of CTGF for the treatment of idiopathic pulmonary fibrosis, locally advanced unresectable pancreatic cancer, and Duchenne muscular dystroph. | |
|
FibroGen (FGEN) has the following price history information. Looking back at FGEN historical stock prices for the last five trading days, on April 15, 2024, FGEN opened at $1.30, traded as high as $1.37 and as low as $1.24, and closed at $1.31. Trading volume was a total of 1.27M shares. On April 16, 2024, FGEN opened at $1.28, traded as high as $1.35 and as low as $1.25, and closed at $1.30. Trading volume was a total of 863.70K shares. On April 17, 2024, FGEN opened at $1.30, traded as high as $1.33 and as low as $1.24, and closed at $1.27. Trading volume was a total of 1.03M shares. On April 18, 2024, FGEN opened at $1.26, traded as high as $1.29 and as low as $1.14, and closed at $1.17. Trading volume was a total of 1.28M shares. On April 19, 2024, FGEN opened at $1.16, traded as high as $1.18 and as low as $1.05, and closed at $1.15. Trading volume was a total of 1.31M shares.
FGEN Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into FibroGen shares, starting with a $10,000 purchase of FGEN, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
11/17/2014 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$23.81 |
|
| End price/share: |
$1.15 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-95.17% |
|
| Average Annual Total Return: |
-27.50% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$482.76 |
|
| Years: |
9.42 |
|
|
|
| Date |
Close |
| 04/15/2024 | $1.31 | | 04/16/2024 | $1.30 | | 04/17/2024 | $1.27 | | 04/18/2024 | $1.17 | | 04/19/2024 | $1.15 |
|
|
Free FGEN Email Alerts:
